Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...

Interleukin 15 expression in asthmatic airways negatively correlated with lung function, a finding that improves ...

A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or ...

Low dose interleukin 2 is being tested as an immunomodulatory approach in neurodegenerative diseases. It increases the number and activity of regulatory T cells (Tregs) that suppress inflammation. At ...

A recent study has revealed how Epstein-Barr virus (EBV) intensifies ulcerative colitis (UC), a debilitating inflammatory ...

Mast cells, which are abundant in the airways of asthmatic individuals, act as first responders to viral infections by ...

Microglia, the brain's immune cells, usually serve as diligent guardians. They eliminate intruders such as microbes and clear ...

Summary: Tocilizumab is a novel monoclonal antibody that competitively inhibits the binding of interleukin-6 (IL-6) to its receptor (IL-6R). Inhibiting the entire receptor complex prevents IL-6 ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...